1. Home
  2. BCIC vs CPIX Comparison

BCIC vs CPIX Comparison

Compare BCIC & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCIC

BCP Investment Corporation

HOLD

Current Price

$5.97

Market Cap

86.6M

Sector

Finance

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$8.04

Market Cap

98.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCIC
CPIX
Founded
2006
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.6M
98.3M
IPO Year
2006
2007

Fundamental Metrics

Financial Performance
Metric
BCIC
CPIX
Price
$5.97
$8.04
Analyst Decision
Hold
Analyst Count
4
0
Target Price
★ $9.83
N/A
AVG Volume (30 Days)
32.3K
★ 43.1K
Earning Date
11-05-2026
11-03-2026
Dividend Yield
★ 17.68%
N/A
EPS Growth
★ 262.50
58.70
EPS
N/A
★ N/A
Revenue
N/A
★ $42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 16.75
52 Week Low
$6.33
$1.85
52 Week High
$13.50
$9.28

Technical Indicators

Market Signals
Indicator
BCIC
CPIX
Relative Strength Index (RSI) 19.05 59.09
Support Level N/A $5.55
Resistance Level $7.57 $8.30
Average True Range (ATR) 0.18 0.62
MACD -0.07 0.06
Stochastic Oscillator 0.87 70.40

Price Performance

Historical Comparison
BCIC
CPIX

About BCIC BCP Investment Corporation

BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Share on Social Networks: